ENDRA Life Sciences Files 8-K
Ticker: NDRA · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
ENDRA filed an 8-K, but details are scarce. Watch for follow-up.
AI Summary
ENDRA Life Sciences Inc. filed an 8-K on July 23, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new agreements.
Why It Matters
This filing indicates a material event has occurred for ENDRA Life Sciences, but the lack of detail requires further investigation to understand its implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events,' which is vague and could represent significant positive or negative developments not yet disclosed.
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Registrant
- July 23, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Ann Arbor, MI (location) — Principal Executive Offices
FAQ
What specific event(s) are being reported under 'Other Events' in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond stating that it is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
When was this 8-K filing submitted to the SEC?
The filing was submitted on July 23, 2025.
What is the principal business address of ENDRA Life Sciences Inc.?
The principal executive offices are located at 3600 Green Court, Suite 350, Ann Arbor, MI 48105.
What is ENDRA Life Sciences Inc.'s IRS Employer Identification Number (EIN)?
ENDRA Life Sciences Inc.'s EIN is 26-0579295.
What is the SIC code for ENDRA Life Sciences Inc.?
The Standard Industrial Classification (SIC) code for ENDRA Life Sciences Inc. is 3845, which corresponds to 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding ENDRA Life Sciences Inc. (NDRA).